Company intelligence / Profile preview

Sound

Seattle, Washington, United Statessoundpharma.com ↗
Ownership
Private
Employees
~20
Development stage
Other
01

Overview

Sound Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing the first regenerative and protective therapies for sensorineural hearing loss and tinnitus. The company's lead candidate, SPI-1005 (ebselen), is a small molecule that mimics the activity of glutathione peroxidase (GPx), a key antioxidant enzyme in the inner ear. SPI-1005 has received FDA Breakthrough Therapy Designation for the treatment of Meniere's disease and is currently in Phase 3 clinical trials. Sound Pharmaceuticals is also exploring SPI-1005 for other neurotologic conditions, including noise-induced hearing loss and ototoxicity, as well as neuropsychiatric disorders.

Therapeutic areas
PsychiatryNeurologyOtherInfectious Diseases
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

5 assets

ebselen

3

4 more assets in the full pipeline.

03

Partnerships

MED-ELCystic Fibrosis Foundation

Beyond the preview

Go deeper on Sound.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sound.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call